Market View 16th January, 2026

View on market: Volatility persists, eagerly searching for growth:

Global markets showed a positive mood as US and European equity futures traded higher, supported by renewed confidence in technology stocks. Strong earnings from a major semiconductor company boosted investor sentiment and helped US markets recover after recent losses. Optimism around artificial intelligence and long-term tech growth has eased worries about high valuations and heavy spending in the sector. Asian markets also remained firm, with technology shares leading the rally. The regional equity index continued its upward trend and touched a fresh high, reflecting strong buying interest, especially in chip-related stocks. Overall, global investors appear more comfortable with the strength of the tech-led market rally.In India, attention is also on key national events. The Prime Minister and the Commerce and Industry Minister are participating in National Start Up Day, highlighting the government’s focus on innovation and entrepreneurship. Japan’s Foreign Minister continues his official visit to India, with diplomatic discussions and a media briefing scheduled. Separately, the President of India is attending a convocation ceremony at a national institute of technology, underlining the importance of higher education and skill development.

Q3FY26 Results for Today:

ADOR, AMAL, ATLASCYCLE, BAJAJHCARE, CAPFIN, CENTRALBK, CHEMBOND, CONTICON, DAMODARIND, EMERALD, FEDERALBNK, GEE, GEOJITFSL, HSCL, INDOBORAX, JAYATMA, JBCHEPHARM, JINDALSAW, JSWINFRA, KESORAMIND, KEYCORP, LTF, MAHEPC, MAPROIN, NEPLOG, NITINFIRE, ONWARDTEC, POLYCAB, POONAWALLA, RELIANCE, SMLMAH, SOBHA, SUNRINV, SURAJLTD, TATATECH, TECHM, THELEELA, TREEHOUSE, VIJIFIN, WALCHPF, WIPRO.

Economic Calendar:

• USD: Initial and Continuing Jobless Claim and GDP Q3 Data on 22^nd January 2026.
• IND: S&P Global Manufacturing and Services PMI Data on 23^rd January 2026.
• USD: S&P Global Manufacturing and Services PMI Data on 23^rd January 2026.
• IND: Foreign Reserves Data on 23^rd January 2026.

Brokerage Radar:

CITI ON GROWW:

Target ₹195 Recommendation Buy, Solid Q3; market share gains across segments, See momentum in MTF, gradual realization of revenues from new segment and pickup in client activity level in broking, Market share gains sustained across categories.

JEFFERIES ON 360 ONE:

Target ₹1410 Recommendation Buy, Dec Qtr: Stronger Flows & Carry Aid Profit Beat; Expect Normalization Ahead, Stronger net flows aided wealth ARR AUM growth of 31% YoY, Higher retentions aided by higher carry income and build-up of UHNI RM teams.

MS ON HDFC LIFE:

Target ₹875 Recommendation Overweight, Q3FY26: VNB beat; APE growth pickup in Q4FY26 will be key, VNB margin beat on better protection mix, favorable yield curve, etc, Trim APE growth and raise VNB margin, with VNB estimates unchanged.

MORGAN STANLEY ON CIPLA:

Target ₹1292 Earlier Target ₹1396 Recommendation Underweight, Lanreotide supply disruption another headwind, Revlimid phase-out and lanreotide supply disruption are likely to result in a weak Q4F26, Cipla’s lanreotide currently has 22% market share.

International Markets:

U.S & Europe:

Particulars	15th  Jan	Chg.	Chg.(%)
Nasdaq	23,530.02	58.27	0.25
Dow	49,442.44	292.81	0.60
FTSE	10,238.94	54.59	0.54
CAC	8,313.12	-17.85	-0.21
DAX	25,352.39	66.15	0.26
Dow Fut.*	49,545.94	103.50	0.21

*As per 16^th January.

Asian markets:

Stocks strong on Chart:

Commodities & Currency:

FIIs & DIIs:

News Updates:

Source: Moneycontrol, Bloomberg Quint, Investing

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 214 

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.

For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India. (SEBI Registration No.: INH100002300)

Disclosure Appendix

Analyst Certification (For Reports)

Vindhyachal Prasad, Elite Wealth Limited, vindhyachal@elitestock.com

The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.

As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:

• all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
• No part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.

Research Excerpts

This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.

Company-Specific Disclosures

Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or emailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.

Options related research:

If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in

Other Disclosures

All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.

Ownership and material conflicts of interest Disclosure

Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.

Country Specific Disclosures

India – For private circulation only, not for sale. Legal Entities Disclosures

Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth  Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone: 011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in

EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:

1. Reports
2. a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;

• EWL or its associates or relatives, have no actual/beneficial ownership of one %. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
• EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;

2. 2. 2. 2. 2. 2. Compensation

• • EWL or its associates have not received any compensation from the subject company in the past twelve months;
  • EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;

• EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
• EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
• EWL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research

3. In respect of Public Appearances

• EWL or its associates have not received any compensation from the subject company in the past twelve months;
• The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL